Latest Nilotinib Stories
LONDON, Nov. 27, 2014 /PRNewswire/ -- INTRODUCTIONTargeted therapeutics is fast emerging as the key focus area in biopharmaceutical industry.
LONDON, August 11, 2014 /PRNewswire/ -- Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United
Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks.
- a meat pie that is usually eaten at Christmas in Quebec